Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 14701-14750 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT04427943
Outcome After Revisions of Infected Knee Arthroplasties
N/AActive, not recruiting
350 participants
Started: Jan 1, 2020 · Completed: Nov 30, 2026
1 condition1 sponsor8 locations
NCT03829475
ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
PHASE2Active, not recruiting
61 participants
Started: Jan 1, 2020 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT04585516
Diagnostic Usefulness of Different Types of Gastrointestinal Endoscopic Investigations.
N/AActive, not recruiting
5,000 participants
Started: Jan 1, 2020 · Completed: Jan 31, 2028
2 conditions1 sponsor1 location
NCT04569851
Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)
N/AActive, not recruiting
100,000 participants
Started: Jan 1, 2020 · Completed: Feb 28, 2024
1 condition2 sponsors2 locations
NCT06611189
A Comparative Analysis of Ray-Tech Sponge and Ice Bag Techniques in Kidney Transplantation
N/AActive, not recruiting
172 participants
Started: Jan 1, 2020 · Completed: Jan 1, 2025
1 condition1 sponsor2 locations
NCT04562259
Verification of Kimmerle's Anomaly by X-ray Methods of Research
N/AActive, not recruiting
100 participants
Started: Jan 1, 2020 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07093827
A Prospective Cohort Study on the Effect of Spinal Spinal Cord Injury on Sexual Function in Male Patients
N/AActive, not recruiting
1,600 participants
Started: Jan 1, 2020 · Completed: Dec 31, 2030
2 conditions2 sponsors1 location
NCT05439954
Radiomics of Autism Spectrum Disorder
N/AActive, not recruiting
230 participants
Started: Jan 1, 2020 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT04856644
Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
PHASE3Active, not recruiting
333 participants
Started: Jan 1, 2020 · Completed: Dec 31, 2024
1 condition5 sponsors4 locations
NCT03989986
iPeer2Peer Program for Youth With Sickle Cell Disease
NAActive, not recruiting
28 participants
Started: Jan 1, 2020 · Completed: Dec 31, 2024
1 condition4 sponsors4 locations
NCT04135989
Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
PHASE4Active, not recruiting
2,106 participants
Started: Jan 1, 2020 · Completed: Oct 24, 2024
4 conditions2 sponsors13 locations
NCT04232462
A Multicentric Validation Study on the Accuracy of Artificial Intelligence Assisted System in Clinical Application of Digestive Endoscopy
N/AActive, not recruiting
10,000 participants
Started: Jan 1, 2020 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT07200765
Efficacy of Combining Caudal Epidural Steroid With Ganglion Impar Block in Chronic Coccydynia
N/AActive, not recruiting
56 participants
Started: Jan 1, 2020 · Completed: Nov 1, 2025
3 conditions1 sponsor1 location
NCT06703346
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
PHASE2Active, not recruiting
87 participants
Started: Dec 31, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor38 locations
NCT03374332
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
PHASE2Active, not recruiting
11 participants
Started: Dec 31, 2019 · Completed: Sep 30, 2024
1 condition4 sponsors1 location
NCT04102098
A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation
PHASE3Active, not recruiting
668 participants
Started: Dec 31, 2019 · Completed: Jul 16, 2027
1 condition1 sponsor134 locations
NCT02923778
Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery
PHASE2Active, not recruiting
40 participants
Started: Dec 31, 2019 · Completed: May 29, 2026
9 conditions1 sponsor17 locations
NCT04219332
Randomized Controlled Trial on Effect of Lymph Node Mapping by Indocyanine Green Via Submucosal or Subserosal Injection
PHASE3Active, not recruiting
266 participants
Started: Dec 31, 2019 · Completed: Oct 28, 2023
3 conditions1 sponsor1 location
NCT04214886
CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies
PHASE1Active, not recruiting
24 participants
Started: Dec 31, 2019 · Completed: Dec 31, 2034
3 conditions2 sponsors1 location
NCT05993299
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
PHASE2Active, not recruiting
7 participants
Started: Dec 31, 2019 · Completed: Jul 1, 2025
1 condition1 sponsor38 locations
NCT04165993
Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer
PHASE2Active, not recruiting
68 participants
Started: Dec 31, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03967223
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors
PHASE2Active, not recruiting
103 participants
Started: Dec 31, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor38 locations
NCT03896503
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
PHASE2Active, not recruiting
104 participants
Started: Dec 30, 2019 · Completed: Jun 23, 2026
6 conditions1 sponsor33 locations
NCT03989206
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
PHASE3Active, not recruiting
1,700 participants
Started: Dec 30, 2019 · Completed: Aug 31, 2026
1 condition1 sponsor343 locations
NCT04626882
Timing of FFR-guided PCI for Non-IRA in STEMI and MVD (OPTION-STEMI)
NAActive, not recruiting
994 participants
Started: Dec 30, 2019 · Completed: Dec 31, 2029
2 conditions1 sponsor14 locations
NCT04221503
Niraparib/TTFields in GBM
PHASE2Active, not recruiting
30 participants
Started: Dec 30, 2019 · Completed: Jan 31, 2026
3 conditions3 sponsors1 location
NCT04165317
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
PHASE3Active, not recruiting
1,070 participants
Started: Dec 30, 2019 · Completed: Dec 2, 2026
1 condition1 sponsor181 locations
NCT04222634
Metastasis-directed Therapy in Castration-refractory Prostate Cancer
NAActive, not recruiting
18 participants
Started: Dec 27, 2019 · Completed: Jan 1, 2030
1 condition1 sponsor1 location
NCT04216576
A Study of the Use of Text Message Reminders to Take Palbociclib
NAActive, not recruiting
45 participants
Started: Dec 27, 2019 · Completed: Dec 27, 2025
1 condition1 sponsor7 locations
NCT04040569
A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast Cancer
PHASE1Active, not recruiting
45 participants
Started: Dec 25, 2019 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT04169997
A Study of IMP4297 as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
PHASE3Active, not recruiting
404 participants
Started: Dec 24, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations
NCT07040150
Evaluation of a Novel Semi-Rigid Brace for Adolescent Idiopathic Scoliosis
N/AActive, not recruiting
60 participants
Started: Dec 24, 2019 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT04343820
Delayed Breast Reconstruction by Prepectoral Implant After Lipo-preparation (RM2prepec)
N/AActive, not recruiting
60 participants
Started: Dec 24, 2019 · Completed: Dec 24, 2024
1 condition1 sponsor1 location
NCT04501913
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
N/AActive, not recruiting
22 participants
Started: Dec 24, 2019 · Completed: Nov 20, 2025
172 conditions2 sponsors1 location
NCT04155749
Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma
PHASE1Active, not recruiting
40 participants
Started: Dec 23, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors4 locations
NCT04150887
Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
PHASE1Active, not recruiting
61 participants
Started: Dec 23, 2019 · Completed: May 15, 2026
1 condition3 sponsors23 locations
NCT04150939
Cryoablation for the Treatment of Metastatic Cancer
NAActive, not recruiting
15 participants
Started: Dec 23, 2019 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT04212013
A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma
PHASE3Active, not recruiting
23 participants
Started: Dec 23, 2019 · Completed: Mar 18, 2027
1 condition2 sponsors10 locations
NCT03967158
Evaluation of Effectiveness and Safety of XIENCE Sierra in Routine Clinical Practice
N/AActive, not recruiting
2,000 participants
Started: Dec 23, 2019 · Completed: Dec 31, 2028
2 conditions2 sponsors10 locations
NCT04225871
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
PHASE3Active, not recruiting
200 participants
Started: Dec 23, 2019 · Completed: Jun 2, 2026
1 condition1 sponsor70 locations
NCT04071951
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
NAActive, not recruiting
6,478 participants
Started: Dec 23, 2019 · Completed: Sep 15, 2025
3 conditions2 sponsors2 locations
NCT04878783
Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG
N/AActive, not recruiting
138 participants
Started: Dec 20, 2019 · Completed: Oct 30, 2027
2 conditions2 sponsors5 locations
NCT04027309
A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy
PHASE3Active, not recruiting
777 participants
Started: Dec 20, 2019 · Completed: Jun 30, 2033
2 conditions3 sponsors193 locations
NCT04356612
Barriers to Efficient PACU Discharge At a Major Academic Orthopaedic Ambulatory Surgery Center
N/AActive, not recruiting
1,000 participants
Started: Dec 20, 2019 · Completed: Nov 6, 2025
2 conditions1 sponsor1 location
NCT04170153
Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)
PHASE1Active, not recruiting
161 participants
Started: Dec 20, 2019 · Completed: Jan 30, 2026
1 condition2 sponsors16 locations
NCT04239625
Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)
PHASE2Active, not recruiting
200 participants
Started: Dec 20, 2019 · Completed: Dec 31, 2026
4 conditions1 sponsor8 locations
NCT04335669
NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC
PHASE3Active, not recruiting
325 participants
Started: Dec 20, 2019 · Completed: Sep 30, 2035
2 conditions3 sponsors24 locations
NCT04175613
A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
PHASE3Active, not recruiting
160 participants
Started: Dec 20, 2019 · Completed: Dec 16, 2025
1 condition1 sponsor50 locations
NCT03904186
Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV
NAActive, not recruiting
360 participants
Started: Dec 19, 2019 · Completed: Feb 28, 2025
7 conditions6 sponsors3 locations
NCT03680508
TSR-022 (anti-TIM-3 Antibody) and TSR-042 (anti-PD-1 Antibody) in Patients with Liver Cancer
PHASE2Active, not recruiting
42 participants
Started: Dec 19, 2019 · Completed: Oct 31, 2027
3 conditions2 sponsors2 locations